Welcome, dear Guest [Log on]

Hall 3, 19/09/2019 (14:15-15:30)



DT-TDS-04-2020: AI for Genomics and Personalised Medicine (RIA)

This call aims to contribute to demonstrating the potential and benefits of AI technologies for identifying new knowledge, support clinical research and decision making by linking Europe's relevant genomic repositories, while ensuring full compliance with data protection legislation and

ethical principles.

DT-TDS-05-2020: AI for Health Imaging (RIA)

This call seeks to take advantage of the advantages offered by applying Artificial Intelligence (AI) solutions in healthcare, in particular in the area of health imaging. It aims to set up and populate a large interoperable repository of health images that will enable the development, testing and validation of AI–based health imaging solutions to improve the diagnosis, disease prediction and follow-up of most common forms of cancer.

SC1-DTH-02-2020: Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies (RIA)

The topic calls for developing and validating comprehensive models based on AI or other state of the art technologies for prediction, prevention and intervention using multiple available data resources and integrating them in personalised health and care pathways that empower individuals to actively contribute to risk mitigation, prevention and targeted intervention.

SC1-DTH-06-2020: Accelerating the uptake of computer simulations for testing medicines and medical devices (RIA)

The specific challenge of this call is accelerating the uptake of individualised computer simulations in the regulatory evaluation of medicines and/or medical devices to become closer to the market., Applicants will provide proofs of validation of computer modelling solutions that gain the trust of regulatory bodies for innovation, in order to, in collaboration with academic and industrial experts, develop the framework of standards, protocols and shared resources required to evaluate the safety and the efficacy of medical devices and/or medicines at the end of the drug development process.

SC1-HCC-06-2020: Coordination and Support to better data and secure cross-border digital infrastructures building on European capacities for genomics and personalised medicine (CSA)

Coordination and support is needed to develop cross-border solutions for sharing expertise and linking genomic and other health data. This should be achieved by identifying relevant initiatives and projects, discerning best practice emerging from clinical implementation and engaging with relevant stakeholders. It is critical to identify common standards for data quality, security, interoperability, privacy, ethical guidelines and governance models

underpinning the establishment of sustainable cross-border digital infrastructures and networks for genomics and personalised medicine in Europe.

Recording of the session

Agenda and other documents

Coordinator: Orestis KALLIANTZIDIS (European Commission, DG CNECT), Costica DUMBRAVA (European Commission, DG CONNECT, Luxembourg), Saila RINNE (European Commission, DG CONNECT, Unit H3 eHealth, Well-Being and Ageing)

Track: Societal Challenges


17 Presentations: Submit your own


5 Topics



Rocío ZARAGOZA, 17/09/2019 12:27

AIJU Research Centre is a non-profit organization aiming to boost research, development and technological innovation within regional industry, thus making it possible the achievement of a constant competitiveness increase and product quality improvement. The main goal of the Therapeutic Leisure for Health area is to develop games and playful applications based on new technologies, using advanced visualization and interfaces interaction, with a high therapeutic value and allow preventive enjoy new entertainment options while improving cognitive and sensory capabilities of the target group. We are experts in serious games for children and elderly people (with or without disabilities), and e-learning. AIJU has created a collaborative games for elderly people also have a significant participation in the definition of existing models (attention, memory, etc.) for different disabilities (Parkinson disease, Alzheimer disease, etc.). We hope the event will be interesting and see you soon.


Comments are closed

ID: 23597